Continued from previous page
Overcoming heparin limitations in PCI with direct thrombin inhibitors
Direct thrombin inhibitors, i.e., univalent agents such as argatroban, and bivalent agents such as lepirudin (Refludan®), desirudin (Revasc®)...
Continued from previous page
Overcoming heparin limitations in PCI with direct thrombin inhibitors
Direct thrombin inhibitors, i.e., univalent agents such as argatroban, and bivalent agents such as lepirudin (Refludan®), desirudin (Revasc®)...
Continued from previous...